From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1
Research pioneer Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named 2023 breakthrough of the year by the Science Magazine.
Source: news-medical.net